Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3440663 | American Journal of Obstetrics and Gynecology | 2008 | 4 Pages |
Abstract
Recurrent/metastatic endometrial adenocarcinoma that is not amenable to cure with local or regional therapy and/or chemotherapy represents a discouraging clinical entity for the clinician. We report the case of 58-year-old woman with recurrent endometrial carcinoma that was resistant to chemotherapy that was treated successfully with the aromatase inhibitor anastrozole.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Stefania Bellone, Hemendrah R. Shah, Jesse K. McKenney, Pamela J.B. Stone, Alessandro D. Santin,